NSE · Basic Materials · Specialty Chemicals
EPS came in at 2.96 against a street estimate of 6.90 — a miss of 57.1%.
with an average price target of ₹2,435.09.
| Holder | Stake |
|---|---|
| Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund | 4.25% |
| SBI Contra Fund | 4.16% |
| Invesco India Elss Tax Saver Fund | 1.92% |
| SBI Life Insurance CO. | 1.68% |
| Mirae Asset Aggressive Hybrid Fund | 1.61% |
| Document | Date |
|---|---|
| Annual report FY2026 NEOGEN CHEMICALS LIMITED – FY 2025-26 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Revenue: ₹862 Crore, +11% YoY (standalone: ₹855 Crore) • EBITD | 2026-07-30 |
| Investor presentation · Q1 FY27 NEOGEN CHEMICALS LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Revenue (Standalone): INR 252.3 crore in Q1 FY27, up 37% from INR 184.6 crore in Q1 FY | 2026-07-26 |
| Investor presentation | 2026-07-26 |
| Quarterly results · Q1 FY27 NEOGEN CHEMICALS LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Q1 FY2026-27 (Quarter ended June 30, 2026) Standalone Results: - Revenue from opera | 2026-07-24 |
| Q4 FY26 earnings call NEOGEN CHEMICALS LIMITED – Q4 FY26 SUMMARY HEADLINE NUMBERS • Q4 FY26 Revenue: INR 247 crore, up 22% YoY • Q4 FY26 EBITDA: INR 44 crore, up 21% YoY; | 2026-05-25 |
| Investor presentation · Q4 FY26 NEOGEN CHEMICALS LIMITED – EARNINGS PRESENTATION SUMMARY HEADLINE NUMBERS • FY26 Revenue (Consolidated): INR 862 crore, up 11% YoY (FY25: INR 777.6 | 2026-05-17 |
| Quarterly results · Q4 FY26 NEOGEN CHEMICALS LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Revenue from operations (FY 2025-26): ₹855.49 crore vs ₹773.65 crore (FY 2024-25) – g | 2026-05-16 |
| Q3 FY26 earnings call NEOGEN CHEMICALS LIMITED – Q3 FY26 SUMMARY FOR RETAIL INVESTORS --- HEADLINE NUMBERS • Q3 FY26 Revenue: INR 220 crore – 9% year-on-year growth • Gr | 2026-02-18 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹1 / share ex-date Aug 13, 2026 | 2026-08-13 |
| Announcement | Date |
|---|---|
| Expansion of Organo-Lithium chemicals facility capacity from 300 to 600 MT annually Neogen Chemicals’ board approved unaudited standalone and consolidated results for the quarter and six months ended September 30, 2026, along with limited-review reports. However, the announ | 2026-10-31 |
| Concludes landmark Joint Venture Agreement with Japan's Morita Investment Neogen Chemicals Limited announced a joint venture (JV) with Japan's Morita Investment to manufacture Electrolyte Salt in India. This is a significant strategic partnership that marks entry | 2025-11-28 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Neogen Chemicals Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.